Boston-based RA Capital Management said that it had closed its inaugural venture fund, RA Capital Nexus Fund (Nexus), at $308m to target life science investing.

The multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies said in a press note that the new fund boosts its private deal capacit